Cetuximab in combination with platinum-based chemotherapy or radiotherapy in recurent and/or metastatic SCCHN in a non-selected patient cohort (interim analysis of the phase IV SOCCER trial)

Hecht M, Hahn D, Beutner D, Reichert D, Goehler T, Wurm R, Welslau M, Renziehausen L, Balermpas P, Bergmann T, Assmann M, Belka C, Orlowski K, Finzsch M, Illerhaus G, Fietkau R (2016)

Publication Type: Conference contribution

Publication year: 2016

Journal

Annals of Oncology Elsevier

Book Volume: 27

Authors with CRIS profile

Markus Hecht Department of Radiation Oncology Rainer Fietkau Lehrstuhl für Strahlentherapie

Involved external institutions

Merck KGaA DE Germany (DE) SRH Wald-Klinikum Gera DE Germany (DE) Klinikum Stuttgart DE Germany (DE) Klinikum Frankfurt (Oder) DE Germany (DE) Onkozentrum Dresden/Freiberg DE Germany (DE) Onkologie Westerstede Aurich Rhauderfehn DE Germany (DE) Elblandkliniken DE Germany (DE) Klinikum der Universität München (Großhadern und Innenstadt) DE Germany (DE) Klinikum Aschaffenburg DE Germany (DE) Universitätsklinikum Frankfurt am Main (KGU) DE Germany (DE) Universitätsklinikum Köln DE Germany (DE)

How to cite

APA:

Hecht, M., Hahn, D., Beutner, D., Reichert, D., Goehler, T., Wurm, R.,... Fietkau, R. (2016). Cetuximab in combination with platinum-based chemotherapy or radiotherapy in recurent and/or metastatic SCCHN in a non-selected patient cohort (interim analysis of the phase IV SOCCER trial).

MLA:

Hecht, Markus, et al. "Cetuximab in combination with platinum-based chemotherapy or radiotherapy in recurent and/or metastatic SCCHN in a non-selected patient cohort (interim analysis of the phase IV SOCCER trial)." 2016.

BibTeX: Download